Rigel Pharmaceuticals RIGL
NASDAQ RIGL
$42.70 +0.65 (+1.55%)
As of: Nov 10, 2026 · 1:07 PM EST

Rigel Pharmaceuticals (RIGL) EV to EBITDA (2024 - 2026)

Updated

Rigel Pharmaceuticals' (RIGL) EV to EBITDA stood at 7.08 in Q2 2026, up 233.1% from 2.13 a year earlier and up 154.4% from the prior quarter.

Analysis

Rigel Pharmaceuticals (RIGL) EV to EBITDA (2024 - 2026) Analysis & Trends

On a TTM basis, Rigel Pharmaceuticals' EV to EBITDA came in at 2.19 as of Jun 30, 2026; for FY2025, it was 4.92, down 41.1% from FY2024.

  • Across earlier years, EV to EBITDA came in at 8.35 in FY2024.
  • The Q2 2026 figure is the highest quarterly EV to EBITDA since Q4 2024.
  • On a year-over-year basis, EV to EBITDA rose in 1 of the last four quarters, with growth averaging 15.2%.
  • Per Business Quant, the preceding three quarters came in at 2.78 (Q1 2026), 4.92 (Q4 2025) and 3.11 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 Rigel Pharmaceuticals 801.35 Mn 305.08 Mn 70.11 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 10.15
Jun 30, 2026 7.08
Mar 31, 2026 2.78
Dec 31, 2025 4.92
Sep 30, 2025 3.11
Jun 30, 2025 2.13
Mar 31, 2025 5.27
Dec 31, 2024 8.35
Sep 30, 2024 19.61
API Access

Rigel Pharmaceuticals EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=RIGL&period=max&api_key=YOUR_API_KEY